Clinical Trial Update: A Study of NanO2™ Combined With Radiation and Temozolomide in Patients With Newly Diagnosed GBM [Phase 2]

View source ↗

Summary

A Phase 2 study evaluating NanO2 combined with radiation and temozolomide in newly diagnosed glioblastoma multiforme is ongoing. The study status is Active Not …

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Glioblastoma Multiforme

Drugs mentioned

• NanO2
• Temozolomide (Temozolomide)

Snippet

Sponsor: NuvOx LLC | Conditions: Glioblastoma Multiforme | Phase 2 | Status: ACTIVE_NOT_RECRUITING